“Our corporate progress in Q1 has matched the pace of our clinical progress ... Clinical Trial Supply Agreement Announced with Regeneron for Libtayo (cemiplimab): In February, Immuneering announced a ...

Key topics include results from the Phase 3 trial of Libtayo for high-risk cutaneous ... like linvoseltamab and odronextamab is still in progress, highlighting uncertainty in their future success ...

The presentation provided insights into the company's clinical progress and strategic direction. A webcast of the presentation is available in the Investors section of the Sensei website.

“With regard to the more personal Siri features we announced, we need more time to complete our work on these features so they meet our high-quality bar. We are making progress, and we look ...

“Our corporate progress in Q1 has matched the pace of our clinical progress. We announced a clinical supply agreement with Regeneron, expanded our cash runway into 2026, and hired an outstanding ...

The Warisan president said, despite five years in power, the Gabungan Rakyat Sabah (GRS) government had failed to deliver meaningful progress ... during its time in government.

Donald Trump’s administration does have some weaknesses and constraints that will constrain their progress ... There is a time constraint bound by when the midterm congressional races start.

"You’re going to be doing it for a very long time, so find a job you enjoy and you’ll never work a day in your life. Money is important, but not at the cost of your happiness. “Nobody starts at the ...

This is the fourth video in the “State Voting Rights Acts: Explained” video series created by the Center for American Progress and the Legal Defense Fund. This video is a collaboration between ...

Positive Lexeo Therapeutics, Inc. interim data from SUNRISE-FA study highlights LX2006's potential for Friedreich's Ataxia.